These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16800102)

  • 1. Pharmacokinetic simulations and AUC: center specificity in the limited sampling model.
    Proost JH
    Int J Clin Pharmacol Ther; 2006 Jun; 44(6):292-3; author reply 293-5. PubMed ID: 16800102
    [No Abstract]   [Full Text] [Related]  

  • 2. Center specificity in the limited sampling model (LSM): can the LSM developed from healthy subjects be extended to disease states?
    Mahmood I
    Int J Clin Pharmacol Ther; 2003 Nov; 41(11):517-23. PubMed ID: 14651035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of organic anion transporting polypeptide in the hepatic uptake of telmisartan in rats: PET studies with [¹¹C]telmisartan.
    Takashima T; Hashizume Y; Katayama Y; Murai M; Wada Y; Maeda K; Sugiyama Y; Watanabe Y
    Mol Pharm; 2011 Oct; 8(5):1789-98. PubMed ID: 21812443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Pharmacokinetic Interaction between Telmisartan and Chlorthalidone in Healthy Male Adult Subjects.
    Seong SJ; Lim MS; Lee J; Ohk B; Gwon MR; Kim BK; Kim HJ; Yang DH; Lee HW; Kang WY; Yoon YR
    Clin Drug Investig; 2016 Aug; 36(8):613-23. PubMed ID: 27206575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of telmisartan in healthy Chinese subjects after oral administration of two dosage levels.
    Zhang P; Zhang Y; Chen X; Li R; Yin J; Zhong D
    Arzneimittelforschung; 2006; 56(8):569-73. PubMed ID: 17009837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-pharmacodynamic modeling of telmisartan using an indirect response model in spontaneously hypertensive rats.
    Hao K; Chen YC; Cao YG; Yu D; Liu XQ; Wang GJ
    Acta Pharmacol Sin; 2007 May; 28(5):738-43. PubMed ID: 17439731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPLC determination of telmisartan in human plasma and its application to a pharmacokinetic study.
    Shen J; Jiao Z; Li ZD; Shi XJ; Zhong MK
    Pharmazie; 2005 Jun; 60(6):418-20. PubMed ID: 15997829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic-pharmacodynamic model of the antihypertensive interaction between telmisartan and hydrochlorothiazide in spontaneously hypertensive rats.
    Hao K; Chen Y; Zhao X; Liu X
    J Pharm Pharmacol; 2014 Aug; 66(8):1112-21. PubMed ID: 24628252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid determination of telmisartan in human plasma by HPLC using a monolithic column with fluorescence detection and its application to a bioequivalence study.
    Zhang H; Jiang Y; Wen J; Zhou T; Fan G; Wu Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3729-33. PubMed ID: 19744898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between pharmacokinetic parameters and occurrence of adverse events in clinical trials performed in Europe and United States for an angiotensin II receptor antagonist, telmisartan.
    Tatami S; Sarashina A; Yamamura N; Igarashi T; Tanigawara Y
    Drug Metab Pharmacokinet; 2004 Feb; 19(1):24-32. PubMed ID: 15499166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic comparison of an angiotensin II receptor antagonist, telmisartan, in Japanese and western hypertensive patients using population pharmacokinetic method.
    Tatami S; Yamamura N; Sarashina A; Yong CL; Igarashi T; Tanigawara Y
    Drug Metab Pharmacokinet; 2004 Feb; 19(1):15-23. PubMed ID: 15499165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetic-pharmacodynamic model of telmisartan and hydrochlorothiazide on blood pressure and plasma potassium after long-term administration in spontaneously hypertensive rats.
    Yu D; Chen Y; Hao K
    Fundam Clin Pharmacol; 2015 Dec; 29(6):543-52. PubMed ID: 26354414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism of ORM1 is associated with the pharmacokinetics of telmisartan.
    Chen WQ; Shu Y; Li Q; Xu LY; Roederer MW; Fan L; Wu LX; He FZ; Luo JQ; Tan ZR; He YJ; Zhou HH; Chen X; Zhang W
    PLoS One; 2013; 8(8):e70341. PubMed ID: 23940561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacogenomic profiles of telmisartan after the oral microdose and therapeutic dose.
    Ieiri I; Nishimura C; Maeda K; Sasaki T; Kimura M; Chiyoda T; Hirota T; Irie S; Shimizu H; Noguchi T; Yoshida K; Sugiyama Y
    Pharmacogenet Genomics; 2011 Aug; 21(8):495-505. PubMed ID: 21691256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interaction of telmisartan with s-amlodipine: an open-label, two-period crossover study in healthy Korean male volunteers.
    Noh YH; Lim HS; Kim MJ; Kim YH; Choi HY; Sung HR; Jin SJ; Lim J; Bae KS
    Clin Ther; 2012 Jul; 34(7):1625-35. PubMed ID: 22721873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid determination of telmisartan in pharmaceuticals and serum by the parallel catalytic hydrogen wave method.
    Xu MT; Song JF; Li N
    Anal Bioanal Chem; 2003 Dec; 377(7-8):1184-9. PubMed ID: 14556044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of single-dose telmisartan 120 mg given during and between hemodialysis in subjects with severe renal insufficiency: comparison with healthy volunteers.
    Stangier J; Su CA; Brickl R; Franke H
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1365-72. PubMed ID: 11185635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers.
    Yamada A; Maeda K; Ishiguro N; Tsuda Y; Igarashi T; Ebner T; Roth W; Ikushiro S; Sugiyama Y
    Pharmacogenet Genomics; 2011 Sep; 21(9):523-30. PubMed ID: 21829131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically based pharmacokinetic prediction of telmisartan in human.
    Li R; Ghosh A; Maurer TS; Kimoto E; Barton HA
    Drug Metab Dispos; 2014 Oct; 42(10):1646-55. PubMed ID: 25092714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH; Matzek KM; Kempthorne-Rawson J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.